Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 340

1.

Risk-benefit assessment of angiotensin II receptor antagonists.

Shusterman N.

Expert Opin Drug Saf. 2002 Jul;1(2):137-52. Review.

PMID:
12904148
2.

[The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].

Bernadet-Monrozies P, Rostaing L, Kamar N, Durand D.

Presse Med. 2002 Nov 9;31(36):1714-20. Review. French.

PMID:
12467154
3.
4.

Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism.

Brunner-La Rocca HP, Vaddadi G, Esler MD.

J Am Coll Cardiol. 1999 Apr;33(5):1163-73. Review.

5.

The future of angiotensin II inhibition in cardiovascular medicine.

Meier P, Maillard M, Burnier M.

Curr Drug Targets Cardiovasc Haematol Disord. 2005 Feb;5(1):15-30. Review.

PMID:
15720221
7.

Update on therapy for heart failure.

DiBianco R.

Am J Med. 2003 Oct 15;115(6):480-8. Review.

PMID:
14563505
9.

The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.

Thomas GN, Chan P, Tomlinson B.

Drugs Aging. 2006;23(2):131-55. Review.

PMID:
16536636
10.
11.

Angiotensin II receptor blockers in the treatment of heart failure.

Peterson RC, Dunlap ME.

Congest Heart Fail. 2002 Sep-Oct;8(5):246-50; 256. Review.

13.
14.
15.
16.

Congestive heart failure: what should be the initial therapy and why?

Chatterjee K.

Am J Cardiovasc Drugs. 2002;2(1):1-6. Review.

PMID:
14727993
17.

ACE inhibitors in heart failure: what more do we need to know?

Demers C, Mody A, Teo KK, McKelvie RS.

Am J Cardiovasc Drugs. 2005;5(6):351-9. Review.

PMID:
16259523
18.

The importance of left ventricular hypertrophy in human hypertension.

Kahan T.

J Hypertens Suppl. 1998 Sep;16(7):S23-9. Review.

PMID:
9855028
19.
20.

RAS inhibition in hypertension.

Ibrahim MM.

J Hum Hypertens. 2006 Feb;20(2):101-8. Review.

PMID:
16397519
Items per page

Supplemental Content

Write to the Help Desk